Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

Company - People | May 06, 2025 | EIN

Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

Ipsen, a global biopharmaceutical company, has announced the appointment of Laura Réveillon as Executive Vice President (EVP) of Strategy & Transformation, effective May 14, 2025. Réveillon, who holds a PhD, will join Ipsen from the Boston Consulting Group where she served as a Partner. Her experience in portfolio strategy, M&A, and operating model transformation is expected to bring a strategic advantage to Ipsen. She will succeed Catherine Abi Habib, who has been appointed General Manager for Belgium and Luxembourg. David Loew, Ipsen’s CEO, welcomed Réveillon, citing her strategic vision and ability to execute transformation projects in the healthcare space as key assets for Ipsen’s ongoing transformation journey. Ipsen focuses on transformative medicines in oncology, rare disease, and neuroscience, and operates globally with partnerships in over 80 countries.

Sectors

  • Biopharmaceutical Industry
  • Management Consulting

Geography

  • France – Ipsen is a biopharmaceutical company with a significant presence in France, including part of its global hubs.
  • United States – Ipsen operates in the U.S. through a sponsored American Depository Receipt program and has a strategic presence in the U.S. healthcare market.

Industry

  • Biopharmaceutical Industry – Ipsen is a global specialty care-driven biopharmaceutical company focused on transformative medicines in oncology, rare diseases, and neuroscience.
  • Management Consulting – Laura Réveillon joins Ipsen from Boston Consulting Group, a management consulting firm, where she specialized in strategy, M&A, and operating model transformations.

Financials

    Participants

    NameRoleTypeDescription
    IpsenCompanyTargetA global specialty care-driven biopharmaceutical company focused on transformative medicines in oncology, rare disease, and neuroscience.
    Laura RéveillonEVP, Strategy & TransformationPersonAppointed as EVP, Strategy & Transformation at Ipsen, effective May 14, 2025. Previously, a Partner at Boston Consulting Group.
    Boston Consulting Group (BCG)Former EmployerCompanyA global management consulting firm where Laura Réveillon served as Partner before joining Ipsen.
    David LoewCEOPersonChief Executive Officer of Ipsen.
    Catherine Abi HabibFormer EVP, Strategy & TransformationPersonFormer EVP, Strategy & Transformation at Ipsen, now appointed as General Manager for Belgium and Luxembourg.